Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters











Publication year range
1.
Behav Brain Res ; 409: 113308, 2021 07 09.
Article in English | MEDLINE | ID: mdl-33872663

ABSTRACT

Improved understanding of the neurophysiological and neurochemical mechanisms underlying schizophrenia is essential for the identification of biological markers and developing new therapeutic targets. The development of behaviorally faithful, predictive animal models is crucial to this endeavor. We have developed a novel two-hit paradigm designed to recapitulate in rodents the developmental process leading to appearance of human schizophrenia symptomatology. The model pairs neonatal administration of the NMDA receptor (NMDAR) open-channel blocker phencyclidine (PCP 10 mg/kg) to male rats at 7, 9 and 11 days of age, with later adolescent exposure (34 days of age) to a single prolonged stress paradigm consisting of 2 h restraint, followed by 20 min of forced swimming. Four experimental groups were examined: vehicle and no stress (VEH-NS), vehicle plus stress (VEH-S), PCP and no stress (PCP-NS), and PCP plus stress (PCP-S). Only pairing of neonatal PCP with single prolonged adolescent stress caused deficits in novel object recognition memory and increased anxiety-like behavior in the elevated plus maze task, without altering locomotor activity. In a separate cohort of animals, the PCP-S group showed significant reduction in magnitude of hippocampal long-term potentiation (LTP) at Schaffer collateral-CA1 synapses following a single pair of theta-burst stimuli (TBS), while LTP was diminished in both PCP treated groups when elicited by a second pair of TBS. These results suggest that the combination of neonatal PCP and acute adolescent stress are necessary for lasting cognitive impairment and anxiety-like phenotype, and that these behavioral impairments may be due to deficits in LTP in hippocampus, and perhaps elsewhere in the brain.


Subject(s)
Behavior, Animal/physiology , Excitatory Amino Acid Antagonists/pharmacology , Phencyclidine/pharmacology , Schizophrenia/etiology , Schizophrenia/physiopathology , Stress, Psychological/complications , Age Factors , Animals , Animals, Newborn , Behavior, Animal/drug effects , Excitatory Amino Acid Antagonists/administration & dosage , Male , Phencyclidine/administration & dosage , Rats , Rats, Sprague-Dawley , Schizophrenia/chemically induced
2.
Sci Rep ; 11(1): 4292, 2021 02 22.
Article in English | MEDLINE | ID: mdl-33619310

ABSTRACT

Galactic cosmic radiation (GCR) composed of high-energy, heavy particles (HZE) poses potentially serious hazards to long-duration crewed missions in deep space beyond earth's magnetosphere, including planned missions to Mars. Chronic effects of GCR exposure on brain structure and cognitive function are poorly understood, thereby limiting risk reduction and mitigation strategies to protect against sequelae from exposure during and after deep-space travel. Given the selective vulnerability of the hippocampus to neurotoxic insult and the importance of this brain region to learning and memory, we hypothesized that GCR-relevant HZE exposure may induce long-term alterations in adult hippocampal neurogenesis, synaptic plasticity, and hippocampal-dependent learning and memory. To test this hypothesis, we irradiated 3-month-old male and female mice with a single, whole-body dose of 10, 50, or 100 cGy 56Fe ions (600 MeV, 181 keV/µm) at Brookhaven National Laboratory. Our data reveal complex, dynamic, time-dependent effects of HZE exposure on the hippocampus. Two months post exposure, neurogenesis, synaptic plasticity and learning were impaired compared to sham-irradiated, age-matched controls. By six months post-exposure, deficits in spatial learning were absent in irradiated mice, and synaptic potentiation was enhanced. Enhanced performance in spatial learning and facilitation of synaptic plasticity in irradiated mice persisted 12 months post-exposure, concomitant with a dramatic rebound in adult-born neurons. Synaptic plasticity and spatial learning remained enhanced 20 months post-exposure, indicating a life-long influence on plasticity and cognition from a single exposure to HZE in young adulthood. These findings suggest that GCR-exposure can persistently alter brain health and cognitive function during and after long-duration travel in deep space.


Subject(s)
Brain/metabolism , Brain/radiation effects , Cosmic Radiation/adverse effects , Astronauts , Biomarkers , Brain/physiopathology , Dentate Gyrus/metabolism , Dentate Gyrus/physiopathology , Dentate Gyrus/radiation effects , Environmental Exposure/adverse effects , Female , Hippocampus/metabolism , Hippocampus/physiopathology , Hippocampus/radiation effects , Humans , Male , Neurogenesis/radiation effects , Radiation Exposure/adverse effects , Space Flight , Spatial Learning/radiation effects , Time Factors
3.
Int J Mol Sci ; 21(4)2020 Feb 20.
Article in English | MEDLINE | ID: mdl-32093363

ABSTRACT

SNAP-25 is essential to activity-dependent vesicle fusion and neurotransmitter release in the nervous system. During early development and adulthood, SNAP-25 appears to have differential influences on short- and long-term synaptic plasticity. The involvement of SNAP-25 in these processes may be different at hippocampal and neocortical synapses because of the presence of two different splice variants, which are developmentally regulated. We show here that the isoform SNAP-25a, which is expressed first developmentally in rodent brain, contributes to developmental regulation of the expression of both long-term depression (LTD) and long-term potentiation (LTP) at Schaffer collateral-CA1 synapses in the hippocampus. In one month old mice lacking the developmentally later expressed isoform SNAP-25b, Schaffer collateral-CA1 synapses showed faster release kinetics, decreased LTP and enhanced LTD. By four months of age, SNAP-25b-deficient mice appeared to have compensated for the lack of the adult SNAP-25b isoform, now exhibiting larger LTP and no differences in LTD compared to wild type mice. Interestingly, learning a hippocampus-dependent task reversed the reductions in LTP, but not LTD, seen at one month of age. In four month old adult mice, learning prevented the compensatory up-regulation of LTD that we observed prior to training. These findings support the hypothesis that SNAP-25b promotes stronger LTP and weakens LTD at Schaffer collateral-CA1 synapses in young mice, and suggest that compensatory mechanisms can reverse alterations in synaptic plasticity associated with a lack of SNAP-25b, once mice reach adulthood.


Subject(s)
CA1 Region, Hippocampal/metabolism , Learning , Long-Term Potentiation , Synapses/metabolism , Synaptosomal-Associated Protein 25/metabolism , Animals , CA1 Region, Hippocampal/cytology , Female , Male , Mice , Mice, Knockout , Protein Isoforms/genetics , Protein Isoforms/metabolism , Synapses/genetics , Synaptosomal-Associated Protein 25/genetics
4.
PLoS One ; 13(11): e0205907, 2018.
Article in English | MEDLINE | ID: mdl-30485271

ABSTRACT

The role of zinc (Zn2+), a modulator of N-methyl-D-aspartate (NMDA) receptors, in regulating long-term synaptic plasticity at hippocampal CA1 synapses is poorly understood. The effects of exogenous application of Zn2+ and of chelation of endogenous Zn2+ were examined on long-term potentiation (LTP) of stimulus-evoked synaptic transmission at Schaffer collateral (SCH) synapses in field CA1 of mouse hippocampal slices using whole-cell patch clamp and field recordings. Low micromolar concentrations of exogenous Zn2+ enhanced the induction of LTP, and this effect required activation of NMDA receptors containing NR2B subunits. Zn2+ elicited a selective increase in NMDA/NR2B fEPSPs, and removal of endogenous Zn2+ with high-affinity Zn2+ chelators robustly reduced the magnitude of stimulus-evoked LTP. Taken together, our data show that Zn2+ at physiological concentrations enhances activation of NMDA receptors containing NR2B subunits, and that this effect enhances the magnitude of LTP.


Subject(s)
CA1 Region, Hippocampal/physiology , Long-Term Potentiation/drug effects , Receptors, N-Methyl-D-Aspartate/metabolism , Synapses/physiology , Zinc/pharmacology , Animals , CA1 Region, Hippocampal/drug effects , Chelating Agents/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Mice, Inbred C57BL , Protein Kinase Inhibitors/pharmacology , Pyramidal Cells/drug effects , Pyramidal Cells/physiology , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Synapses/drug effects , src-Family Kinases/antagonists & inhibitors , src-Family Kinases/metabolism
5.
Brain ; 141(2): 422-458, 2018 02 01.
Article in English | MEDLINE | ID: mdl-29360998

ABSTRACT

The mechanisms underpinning concussion, traumatic brain injury, and chronic traumatic encephalopathy, and the relationships between these disorders, are poorly understood. We examined post-mortem brains from teenage athletes in the acute-subacute period after mild closed-head impact injury and found astrocytosis, myelinated axonopathy, microvascular injury, perivascular neuroinflammation, and phosphorylated tau protein pathology. To investigate causal mechanisms, we developed a mouse model of lateral closed-head impact injury that uses momentum transfer to induce traumatic head acceleration. Unanaesthetized mice subjected to unilateral impact exhibited abrupt onset, transient course, and rapid resolution of a concussion-like syndrome characterized by altered arousal, contralateral hemiparesis, truncal ataxia, locomotor and balance impairments, and neurobehavioural deficits. Experimental impact injury was associated with axonopathy, blood-brain barrier disruption, astrocytosis, microgliosis (with activation of triggering receptor expressed on myeloid cells, TREM2), monocyte infiltration, and phosphorylated tauopathy in cerebral cortex ipsilateral and subjacent to impact. Phosphorylated tauopathy was detected in ipsilateral axons by 24 h, bilateral axons and soma by 2 weeks, and distant cortex bilaterally at 5.5 months post-injury. Impact pathologies co-localized with serum albumin extravasation in the brain that was diagnostically detectable in living mice by dynamic contrast-enhanced MRI. These pathologies were also accompanied by early, persistent, and bilateral impairment in axonal conduction velocity in the hippocampus and defective long-term potentiation of synaptic neurotransmission in the medial prefrontal cortex, brain regions distant from acute brain injury. Surprisingly, acute neurobehavioural deficits at the time of injury did not correlate with blood-brain barrier disruption, microgliosis, neuroinflammation, phosphorylated tauopathy, or electrophysiological dysfunction. Furthermore, concussion-like deficits were observed after impact injury, but not after blast exposure under experimental conditions matched for head kinematics. Computational modelling showed that impact injury generated focal point loading on the head and seven-fold greater peak shear stress in the brain compared to blast exposure. Moreover, intracerebral shear stress peaked before onset of gross head motion. By comparison, blast induced distributed force loading on the head and diffuse, lower magnitude shear stress in the brain. We conclude that force loading mechanics at the time of injury shape acute neurobehavioural responses, structural brain damage, and neuropathological sequelae triggered by neurotrauma. These results indicate that closed-head impact injuries, independent of concussive signs, can induce traumatic brain injury as well as early pathologies and functional sequelae associated with chronic traumatic encephalopathy. These results also shed light on the origins of concussion and relationship to traumatic brain injury and its aftermath.awx350media15713427811001.


Subject(s)
Athletic Injuries/complications , Brain Concussion/etiology , Craniocerebral Trauma/complications , Craniocerebral Trauma/etiology , Tauopathies/etiology , Vascular System Injuries/etiology , Action Potentials/physiology , Adolescent , Animals , Athletes , Brain/pathology , Calcium-Binding Proteins , Cohort Studies , Computer Simulation , Craniocerebral Trauma/diagnostic imaging , DNA-Binding Proteins/metabolism , Disease Models, Animal , Female , Gene Expression Regulation/physiology , Hippocampus/physiopathology , Humans , Male , Mice , Mice, Inbred C57BL , Microfilament Proteins , Models, Neurological , Prefrontal Cortex/physiopathology , Receptors, CCR2/genetics , Receptors, CCR2/metabolism , Receptors, Interleukin-8A/genetics , Receptors, Interleukin-8A/metabolism , Young Adult
6.
Curr Neuropharmacol ; 15(1): 71-86, 2017.
Article in English | MEDLINE | ID: mdl-26830964

ABSTRACT

The development of a persistent depressive affective state has for some time been thought to result from persistent alterations in neurotransmitter-mediated synaptic transmission. While the identity of those transmitters has changed over the years, the literature has lacked mechanistic connections between the neurophysiological mechanisms they regulate, and how these mechanisms alter neuronal function, and, hence, affective homeostasis. This review will examine recent work that suggests that both long-term activity-dependent changes in synaptic strength ("plasticity"), and shifting set points for the ease of induction of future long-term changes ("metaplasticity"), may be critical to establishing and reversing a depressive behavioral state. Activitydependent long-term synaptic plasticity involves both strengthening and weakening of synaptic connections associated with a dizzying array of neurochemical alterations that include synaptic insertion and removal of a number of subtypes of AMPA, NMDA and metabotropic glutamate receptors, changes in presynaptic glutamate release, and structural changes in dendritic spines. Cellular mechanisms of metaplasticity are far less well understood. Here, we will review the growing evidence that long-term synaptic changes in glutamatergic transmission, in brain regions that regulate mood, are key determinants of affective homeostasis and therapeutic targets with immense potential for drug development.


Subject(s)
Brain/pathology , Depression/pathology , Neuronal Plasticity/physiology , Receptors, Glutamate/metabolism , Synapses/physiology , Animals , Brain/physiopathology , Humans , Synaptic Transmission/physiology
7.
Cereb Cortex ; 26(5): 2242-2256, 2016 May.
Article in English | MEDLINE | ID: mdl-25882040

ABSTRACT

In humans, the developmental origins of interneurons in the third trimester of pregnancy and the timing of completion of interneuron neurogenesis have remained unknown. Here, we show that the total and cycling Nkx2.1(+)and Dlx2(+)interneuron progenitors as well as Sox2(+)precursor cells were higher in density in the medial ganglionic eminence (MGE) compared with the lateral ganglionic eminence and cortical ventricular/subventricular zone (VZ/SVZ) of 16-35 gw subjects. The proliferation of these progenitors reduced as a function of gestational age, almost terminating by 35 gw. Proliferating Dlx2(+)cells were higher in density in the caudal ganglionic eminence (CGE) compared with the MGE, and persisted beyond 35 gw. Consistent with these findings, Sox2, Nkx2.1, Dlx2, and Mash1 protein levels were higher in the ganglionic eminences relative to the cortical VZ/SVZ. The density of gamma-aminobutyric acid-positive (GABA(+)) interneurons was higher in the cortical VZ/SVZ relative to MGE, but Nkx2.1 or Dlx2-expressing GABA(+)cells were more dense in the MGE compared with the cortical VZ/SVZ. The data suggest that the MGE and CGE are the primary source of cortical interneurons. Moreover, their generation continues nearly to the end of pregnancy, which may predispose premature infants to neurobehavioral disorders.


Subject(s)
Brain/embryology , Brain/physiology , Fetal Development , GABAergic Neurons/physiology , Interneurons/physiology , Neural Stem Cells/physiology , Brain/metabolism , Cell Count , Cerebral Cortex/embryology , Cerebral Cortex/metabolism , Cerebral Cortex/physiology , Female , GABAergic Neurons/metabolism , Gestational Age , Homeodomain Proteins/metabolism , Humans , Interneurons/metabolism , Lateral Ventricles/embryology , Lateral Ventricles/metabolism , Lateral Ventricles/physiology , Male , Median Eminence/embryology , Median Eminence/physiology , Neural Stem Cells/metabolism , Neurogenesis , Nuclear Proteins/metabolism , Pregnancy , Pregnancy Trimester, Third , Thyroid Nuclear Factor 1 , Transcription Factors/metabolism
8.
Exp Neurol ; 263: 200-13, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25263581

ABSTRACT

Postnatal glucocorticoids (GCs) are widely used in the prevention of chronic lung disease in premature infants. Their pharmacologic use is associated with neurodevelopmental delay and cerebral palsy. However, the effect of GC dose and preparation (dexamethasone versus betamethasone) on short and long-term neurological outcomes remains undetermined, and the mechanisms of GC-induced brain injury are unclear. We hypothesized that postnatal GC would induce hypomyelination and motor impairment in a preparation- and dose-specific manner, and that GC receptor (GR) inhibition might restore myelination and neurological function in GC-treated animals. Additionally, GC-induced hypomyelination and neurological deficit might be transient. To test our hypotheses, we treated prematurely delivered rabbit pups with high (0.5mg/kg/day) or low (0.2mg/kg/day) doses of dexamethasone or betamethasone. Myelin basic protein (MBP), oligodendrocyte proliferation and maturation, astrocytes, transcriptomic profile, and neurobehavioral functions were evaluated. We found that high-dose GC treatment, but not low-dose, reduced MBP expression and impaired motor function at postnatal day 14. High-dose dexamethasone induced astrogliosis, betamethasone did not. Mifepristone, a GR antagonist, reversed dexamethasone-induced myelination, but not astrogliosis. Both GCs inhibited oligodendrocyte proliferation and maturation. Moreover, high-dose dexamethasone altered genes associated with myelination, cell-cycle, GR, and mitogen-activated protein kinase. Importantly, GC-induced hypomyelination, gliosis, and motor-deficit, observed at day 14, completely recovered by day 21. Hence, high-dose, but not low-dose, postnatal GC causes reversible reductions in myelination and motor functions. GC treatment induces hypomyelination by GR-dependent genomic mechanisms, but astrogliosis by non-genomic mechanisms. GC-induced motor impairment and neurodevelopmental delay might be transient and recover spontaneously in premature infants.


Subject(s)
Brain/drug effects , Glucocorticoids/adverse effects , Myelin Sheath/drug effects , Animals , Animals, Newborn , Betamethasone/administration & dosage , Betamethasone/adverse effects , Blotting, Western , Brain/pathology , Dexamethasone/administration & dosage , Dexamethasone/adverse effects , Disease Models, Animal , Dose-Response Relationship, Drug , Gliosis/chemically induced , Gliosis/pathology , Glucocorticoids/administration & dosage , Immunohistochemistry , In Situ Nick-End Labeling , Myelin Sheath/pathology , Rabbits , Real-Time Polymerase Chain Reaction , Receptors, Glucocorticoid/metabolism
9.
J Neurosci ; 33(44): 17232-46, 2013 Oct 30.
Article in English | MEDLINE | ID: mdl-24174657

ABSTRACT

Intraventricular hemorrhage (IVH) remains a major cause of white matter injury in preterm infants with no viable therapeutic strategy to restore myelination. Maturation of oligodendrocytes and myelination is influenced by thyroid hormone (TH) signaling, which is mediated by TH receptor α (TRα) and TRß. In the brain, cellular levels of TH are regulated by deiodinases, with deiodinase-2 mediating TH activation and deiodinase-3 TH inactivation. Therefore, we hypothesized that IVH would decrease TH signaling via changes in the expression of deiodinases and/or TRs, and normalization of TH signaling would enhance maturation of oligodendrocytes and myelination in preterm infants with IVH. These hypotheses were tested using both autopsy materials from human preterm infants and a rabbit model of IVH. We found that deiodinase-2 levels were reduced, whereas deiodinase-3 levels were increased in brain samples of both humans and rabbits with IVH compared with controls without IVH. TRα expression was also increased in human infants with IVH. Importantly, treatment with TH accelerated the proliferation and maturation of oligodendrocytes, increased transcription of Olig2 and Sox10 genes, augmented myelination, and restored neurological function in pups with IVH. Consistent with these findings, the density of myelinating oligodendrocytes was almost doubled in TH-treated human preterm infants compared with controls. Thus, in infants with IVH the combined elevation in deiodinase-3 and reduction in deiodinase-2 decreases TH signaling that can be worsened by an increase in unliganded TRα. Given that TH promotes neurological recovery in IVH, TH treatment might improve the neurodevelopmental outcome of preterm infants with IVH.


Subject(s)
Cerebral Hemorrhage/drug therapy , Cerebral Hemorrhage/physiopathology , Cerebral Ventricles/physiopathology , Myelin Sheath/physiology , Recovery of Function/physiology , Thyroxine/physiology , Animals , Animals, Newborn , Cerebral Ventricles/physiology , Disease Models, Animal , Double-Blind Method , Female , Humans , Infant, Newborn , Infant, Premature , Male , Myelin Sheath/pathology , Rabbits , Thyroxine/therapeutic use , Treatment Outcome
10.
J Neurosci ; 33(2): 411-23, 2013 Jan 09.
Article in English | MEDLINE | ID: mdl-23303921

ABSTRACT

Premature infants exhibit neurodevelopmental delay and reduced growth of the cerebral cortex. However, the underlying mechanisms have remained elusive. Therefore, we hypothesized that neurogenesis in the ventricular and subventricular zones of the cerebral cortex would continue in the third trimester of pregnancy and that preterm birth would suppress neurogenesis. To test our hypotheses, we evaluated autopsy materials from human fetuses and preterm infants of 16-35 gestational weeks (gw). We noted that both cycling and noncycling Sox2(+) radial glial cells and Tbr2(+) intermediate progenitors were abundant in human preterm infants until 28 gw. However, their densities consistently decreased from 16 through 28 gw. To determine the effect of premature birth on neurogenesis, we used a rabbit model and compared preterm [embryonic day 29 (E29), 3 d old] and term (E32, <2 h old) pups at an equivalent postconceptional age. Glutamatergic neurogenesis was suppressed in preterm rabbits, as indicated by the reduced number of Tbr2(+) intermediate progenitors and the increased number of Sox2(+) radial glia. Additionally, hypoxia-inducible factor-1α, vascular endothelial growth factor, and erythropoietin were higher in term than preterm pups, reflecting the hypoxic intrauterine environment of just-born term pups. Proneural genes, including Pax6 and Neurogenin-1 and -2, were higher in preterm rabbit pups compared with term pups. Importantly, neurogenesis and associated factors were restored in preterm pups by treatment with dimethyloxallyl glycine, a hypoxia mimetic agent. Hence, glutamatergic neurogenesis continues in the premature infants, preterm birth suppresses neurogenesis, and hypoxia-mimetic agents might restore neurogenesis, enhance cortical growth, and improve neurodevelopmental outcome of premature infants.


Subject(s)
Neurogenesis/physiology , Pregnancy Trimester, Third/physiology , Premature Birth/physiopathology , Adult , Animals , Cell Count , Cerebral Ventricles/growth & development , Erythropoietin/physiology , Female , Gestational Age , Glycine/pharmacology , Humans , Hypoxia/physiopathology , Hypoxia-Inducible Factor 1/biosynthesis , Hypoxia-Inducible Factor 1/physiology , Immunohistochemistry , Infant, Newborn , Infant, Premature , Male , Nerve Tissue Proteins/biosynthesis , Neural Stem Cells/physiology , Pregnancy , Rabbits , Signal Transduction/physiology , Telencephalon/growth & development , Vascular Endothelial Growth Factor A/physiology , Wnt Proteins/physiology , beta Catenin/physiology
SELECTION OF CITATIONS
SEARCH DETAIL